These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1378934)

  • 21. The ninth component of human complement (C9). Functional activity of the b fragment.
    Shiver JW; Dankert JR; Donovan JJ; Esser AF
    J Biol Chem; 1986 Jul; 261(21):9629-36. PubMed ID: 2426252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The architecture of complement component C9 and poly(C9).
    DiScipio RG; Hugli TE
    J Biol Chem; 1985 Nov; 260(27):14802-9. PubMed ID: 4055801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affinity of the C9 molecule for the C5b-8 complex compared with that for the complex containing C9 molecules.
    MacKay SL; Dankert JR
    Infect Immun; 1994 Jul; 62(7):2800-5. PubMed ID: 8005670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the mechanism of cell membrane damage by complement: evidence on insertion of polypeptide chains from C8 and C9 into the lipid bilayer of erythrocytes.
    Hammer CH; Shin ML; Abramovitz AS; Mayer MM
    J Immunol; 1977 Jul; 119(1):1-8. PubMed ID: 559700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of polymerization of a fluoresceinated derivative of complement protein C9 by the membrane-bound complex of complement proteins C5b-8.
    Sims PJ; Wiedmer T
    Biochemistry; 1984 Jul; 23(14):3260-7. PubMed ID: 6432040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage.
    Sims PJ
    Biochim Biophys Acta; 1983 Aug; 732(3):541-52. PubMed ID: 6871214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluid-phase assembly of the membrane attack complex of complement.
    Silversmith RE; Nelsestuen GL
    Biochemistry; 1986 Feb; 25(4):841-51. PubMed ID: 3964648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni.
    Deng J; Gold D; LoVerde PT; Fishelson Z
    Int J Parasitol; 2007 Jan; 37(1):67-75. PubMed ID: 17123534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation of the C9b fragment of human complement component C9 using urea in the absence of detergents.
    Gu X; Dankert JR
    J Immunol Methods; 1996 Jan; 189(1):37-45. PubMed ID: 8576578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potent inhibition of terminal complement assembly by clusterin: characterization of its impact on C9 polymerization.
    McDonald JF; Nelsestuen GL
    Biochemistry; 1997 Jun; 36(24):7464-73. PubMed ID: 9200695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neoepitope of the complement C5b-9 Membrane Attack Complex is formed by proximity of adjacent ancillary regions of C9.
    Bayly-Jones C; Ho BHT; Lau C; Leung EWW; D'Andrea L; Lupton CJ; Ekkel SM; Venugopal H; Whisstock JC; Mollnes TE; Spicer BA; Dunstone MA
    Commun Biol; 2023 Jan; 6(1):42. PubMed ID: 36639734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenic crossreactivity of the alpha subunit of complement component C8 with the cysteine-rich domain shared by complement component C9 and low density lipoprotein receptor.
    Tschopp J; Mollnes TE
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4223-7. PubMed ID: 2424021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
    Joiner KA; Tartanian AB; Hammer CH; Schweinle JE
    J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular analysis of the membrane attack mechanism of complement.
    Kolb WP; Haxby JA; Arroyave CM; Müller-Eberhard HJ
    J Exp Med; 1972 Mar; 135(3):549-66. PubMed ID: 5058233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
    Tschopp J; Chonn A; Hertig S; French LE
    J Immunol; 1993 Aug; 151(4):2159-65. PubMed ID: 8345200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using polymerized C9 to produce a monoclonal antibody against a neoantigen of the human terminal complement complex.
    Kusunoki Y; Takekoshi Y; Nagasawa S
    J Pharmacobiodyn; 1990 Jul; 13(7):454-60. PubMed ID: 2290128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrastructure of the membrane attack complex of complement. Heterogeneity of the complex caused by different degree of C9 polymerization.
    Tschopp J
    J Biol Chem; 1984 Jun; 259(12):7857-63. PubMed ID: 6736027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The functions of the ninth component of human complement are sustained by disulfide bonds with different susceptibilities to reduction.
    Hatanaka M; Seya T; Inai S; Shimizu A
    Biochim Biophys Acta; 1994 Nov; 1209(1):117-22. PubMed ID: 7947973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies against neoantigens of the terminal C5b-9 complex of human complement.
    Hugo F; Jenne D; Bhakdi S
    Biosci Rep; 1985 Aug; 5(8):649-58. PubMed ID: 2415178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane permeability to macromolecules mediated by the membrane attack complex.
    Malinski JA; Nelsestuen GL
    Biochemistry; 1989 Jan; 28(1):61-70. PubMed ID: 2706268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.